Combining Low-Dose MDMA with Psilocybin or LSD May Enhance the Acute Subjective Psychedelic Experience

Low-dose MDMA combined with classic psychedelics (psilocybin or LSD) may improve acute subjective experiences, based on a sample of naturalistic psychedelic users. The findings link low-dose MDMA co-use to fewer acute challenging experiences compared to classic psychedelics alone, including reductions in fear and grief. Low-dose MDMA co-use was also associated with increased self-compassion, love, and gratitude during the acute psychedelic experience. Dose may matter: medium or high doses of MDMA did not show the same pattern of reduced challenging aspects or enhanced positive elements. The report notes limitations such as a convenience sample, small size, and non-experimental design, and frames the results as preliminary evidence that could motivate future controlled studies on safety and potential roles in psychedelic-assisted settings.